NCT06268093View on ClinicalTrials.gov

The Therapeutic Effect of Thalidomide in Syringomyelia

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

February 29, 2028

Conditions

SyringomyeliaThalidomide

Interventions

DRUG

Thalidomide

Thalidomide 50 - 200 mg once at nightime

Trial Locations (1)

100032

RECRUITING

Fengzeng Jian, Beijing

All Listed Sponsors

lead

Xuanwu Hospital, Beijing

OTHER